Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

BACKGROUND: Aspirin and heparin are widely used as preventive strategy to reduce the high risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This review supersedes a previous, out‐of‐date review that evaluated all potential therapies for preventing recurrent pregnancy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: Hamulyák, Eva N, Scheres, Luuk JJ, Marijnen, Mauritia C, Goddijn, Mariëtte, Middeldorp, Saskia
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2020
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7195627/
https://ncbi.nlm.nih.gov/pubmed/32358837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012852.pub2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares